C4 Therapeutics
CCCC
CCCC
114 hedge funds and large institutions have $103M invested in C4 Therapeutics in 2025 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 39 increasing their positions, 29 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.94% less ownership
Funds ownership: 91.23% → 90.3% (-0.94%)
56% less capital invested
Capital invested by funds: $232M → $103M (-$129M)
Holders
114
Holding in Top 10
1
Calls
$127K
Puts
$4K
Top Buyers
| 1 | +$3.92M | |
| 2 | +$1.12M | |
| 3 | +$1.04M | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$780K |
| 5 |
SG Americas Securities
New York
|
+$680K |
Top Sellers
| 1 | -$17.6M | |
| 2 | -$1.02M | |
| 3 | -$558K | |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$542K |
| 5 |
M&T Bank
Buffalo,
New York
|
-$478K |
